✦ LIBER ✦

AS602868, a dual inhibitor of IKK2 and FLT3 to target AML cells

✍ Scribed by Griessinger, E; Imbert, V; Lagadec, P; Gonthier, N; Dubreuil, P; Romanelli, A; Dreano, M; Peyron, J-F

Book ID: 110057131
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 453 KB
Volume: 21
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2404614

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The FLT3 and Pim kinases inhibitor SGI-1

The FLT3 and Pim kinases inhibitor SGI-1776 preferentially target FLT3-ITD AML cells

✍ Hospital, M.-A.; Green, A. S.; Lacombe, C.; Mayeux, P.; Bouscary, D.; Tamburini, 📂 Article 📅 2012 🏛 American Society of Hematology 🌐 English ⚖ 260 KB

Lyn is an important component of the sig

Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITD

✍ Okamoto, M; Hayakawa, F; Miyata, Y; Watamoto, K; Emi, N; Abe, A; Kiyoi, H; Towat 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 281 KB

DNA repair contributes to the drug-resis

DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412

✍ Seedhouse, C H; Hunter, H M; Lloyd-Lewis, B; Massip, A-M; Pallis, M; Carter, G I 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 151 KB

The Histone Deacetylase Inhibitor SAHA S

The Histone Deacetylase Inhibitor SAHA Sensitizes AML Cells to a Combination of Nucleoside Analogs and the DNA-Alkylating Agent Busulfan

✍ Wang, Guiyun; Valdez, Ben; Li, Yang; Dominguez, Jose R.; Champlin, Richard E.; A 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 51 KB

IL-2 as a therapeutic target for the res

IL-2 as a therapeutic target for the restoration of Foxp3+regulatory T cell function in organ-specific autoimmunity: implications in pathophysiology and translation to human disease

✍ Eva d'Hennezel; Mara Kornete; Ciriaco A Piccirillo 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 771 KB

606 POSTER Augmented growth inhibition o

606 POSTER Augmented growth inhibition of human NSCLC cells resistant to EGFR-tyrosine kinase inhibitor (TKl) by a combination of dual TKl of EGFR/VEGFR2 (AEE788) and mTOR inhibitor (RAD001)

✍ K. Soejima; I. Nakachi; K. Naoki; H. Watanabe; I. Kawada; H. Yasuda; A. Ishizaka 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB